The use of Dermicol-P35 dermal filler for nonsurgical rhinoplasty.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19577178.
- Also identified by DOI 10.1016/j.asj.2009.03.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A growing number of patients with congenital or acquired nasal defects is seeking nonsurgical procedures to correct the appearance of their nose. The use of fillers for the correction of nasal deformities is expanding because of their low risk and reversibility compared with surgery. Dermicol-P35 (Evolence; Ortho Dermatologics, Skillman, NJ) is a novel crosslinked, fibrillar type I collagen isolated from porcine tendons that has not been associated with the same degree of immunogenicity as bovine collagen. The use of Dermicol-P35 in this study of 12 subjects was associated with high tolerance, as well as a high degree of satisfaction.
Medical subject headings
- Biocompatible Materials
- Collagen
- Cosmetic Techniques
- Dermatologic Agents
- Nose Deformities, Acquired
- Rejuvenation
- Rhinoplasty